CD49d promotes disease progression in chronic lymphocytic leukemia: new insights from CD49d bimodal expression

CD49d is a remarkable prognostic biomarker of chronic lymphocytic leukemia (CLL). The cutoff value for the extensively validated 30% of positive CLL cells is able to separate CLL patients into 2 subgroups with different prognoses, but it does not consider the pattern of CD49d expression. In the pres...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood
Main Authors: Tissino, Erika, Pozzo, Federico, Benedetti, Dania, Caldana, Chiara, Bittolo, Tamara, Rossi, Francesca Maria, Bomben, Riccardo, Nanni, Paola, Chivilò, Hillarj, Cattarossi, Ilaria, Zaina, Eva, Norris, Kevin, Polesel, Jerry, Gentile, Massimo, Tripepi, Giovanni, Moia, Riccardo, Santinelli, Enrico, Innocenti, Idanna, Olivieri, Jacopo, D’Arena, Giovanni, Laurenti, Luca, Zaja, Francesco, Pozzato, Gabriele, Chiarenza, Annalisa, Di Raimondo, Francesco, Rossi, Davide, Pepper, Chris, Hartmann, Tanja Nicole, Gaidano, Gianluca, Del Poeta, Giovanni, Gattei, Valter, Zucchetto, Antonella
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2020
Assuntos:
Lymphoid Neoplasia
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7228464/
https://ncbi.nlm.nih.gov/pubmed/32006000
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood.2019003179
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados